Company profile
Lowell Farms Inc.
OTC: LOWLF · Healthcare · Drug Manufacturers - Specialty & Generic
#514 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 27GM —SS 35
v0.1 · 25/100 weight · pillars only
↑ growth stability, workforce scale · ↓ market scale, return on equity
Methodology →Revenue TTM
$19.3M
Rev growth YoY (TTM)
-35.7%
Net income (FY)
-$37.3M
Employees
96
as of 2026-07-12
Market cap
$1.8k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$28.3M$28.3M2023
Net income-$37.3M-$37.3M2023
Operating income-$17.6M-$17.6M2023
Total assets$37.6M$37.6M2023
Liabilities$26.1M$26.1M2023
Equity$11.5M$11.5M2023
Revenue trend
FY2021 – FY2023 · USD
FY21
FY21
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Lowell Farms Inc.’s revenue?
Lowell Farms Inc. booked $28.3M in FY2023 revenue, contracting 35% year over year — slower than 77% of Healthcare companies we track, at a -132.1% net margin.
Peers · Healthcare
Nanalysis Scientific Corp.59COscar Health, Inc.50DBionano Genomics, Inc.48DAmerican Shared Hospital Services59CImmuCell Corporation63CSensus Healthcare, Inc.51DNeighbors
Monterey →Key facts
CEOMark Luciano Ainsworth
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSalinas, CA
ExchangeOTC: LOWLF
Employees96
IPO date2019-05-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.